Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance

BACKGROUND/AIMS: Real-world data about the treatment outcomes of patients receiving rituximab-containing immunochemotherapy followed by rituximab maintenance are required to understand better the treatment for follicular lymphoma (FL). METHODS: A cross-sectional study analyzed FL patients who were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Kyung, Kang, Wonseok, Sinn, Dong Hyun, Lee, Joon Hyeok, Kim, Won Seog, Kim, Seok Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960034/
https://www.ncbi.nlm.nih.gov/pubmed/30935195
http://dx.doi.org/10.3904/kjim.2018.196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960034/
https://www.ncbi.nlm.nih.gov/pubmed/30935195
http://dx.doi.org/10.3904/kjim.2018.196

Ejemplares similares